Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin

Lorenz Thurner, Antje Müller*, Martine Cérutti, Thierry Martin, Jean Louis Pasquali, Wolfgang L. Gross, Klaus Dieter Preuss, Michael Pfreundschuh, Jan Voswinkel

*Corresponding author for this work
33 Citations (Scopus)

Abstract

Wegener's granulomatosis (WG) is a severe autoimmune disorder ranging from localized granulomatous disease to generalised anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A previous analysis of immunoglobulin heavy chain genes derived from tissue, i.e. Wegener's granuloma indicated selection and affinity maturation towards local antigen(s). The current study focused on determining the specificity of immunoglobulins from distinct B lymphocytes out of Wegener's granuloma. Four pairs of variable region immunoglobulin light and heavy chain genes, isolated before, were recombinantly expressed using the baculovirus/insect cell system. These immunoglobulins were then analysed for their antigenic target employing a protein macroarray based upon a human fetal brain tissue cDNA expression library. The lysosomal transmembrane protein 9B, a key regulator for TNFα activation, was identified as the putative antigenic target of two immunoglobulins and a tetraspanin, which might play a role in leukocyte activation and motility, was identified as the putative antigenic target of another one. Recombinant monoclonal antibodies out of Wegener's granuloma represent a new tool aiding in elucidation of its and WG immunopathogenesis.

Original languageEnglish
JournalJournal of Autoimmunity
Volume36
Issue number1
Pages (from-to)87-90
Number of pages4
ISSN0896-8411
DOIs
Publication statusPublished - 01.02.2011

Funding

The study has been supported by a grant from the Germany Research Society (DFG) to the Clinical Research Unit 170 (AM, WLG), which is associated with the DFG-funded Cluster of Excellence “Inflammation at Interfaces” as junior research group (JRG I-h). The funding sources had no involvement in study design, collection, analysis and interpretation of data, in the writing of the report as well as in the decision to submit the paper for publication. We apprecciate the superb technical assistance of Birgit Bette, Gabriele Carbon, Natalie Fadle and Silke Pitann. Authorship contributions: JV, AM and WLG conceived of and designed the study. MC and LT performed the cloning and recombinant expression of the immunoglobulins. LT and KDP performed the protein array experiments. TM and JLP participated in the development of the study. LT, AM, MP and JV are responsible for data analysis, interpretation of results and writing of the manuscript. Disclosure of conflicts of interest: The authors declare no conflicts of interest.

Fingerprint

Dive into the research topics of 'Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin'. Together they form a unique fingerprint.
  • CRU 170: Early Pathogenesis of Wegener's Granulomatosis: From Innate Immunity with Granuloma Formation to Autoimmunity.

    Gross, W. (Speaker, Coordinator), Lamprecht, P. (Speaker, Coordinator), Ambrosch, P. (Principal Investigator (PI)), Gottschlich, S. (Principal Investigator (PI)), Müller, A. (Principal Investigator (PI)), Ullrich, M. S. (Principal Investigator (PI)), Wieczorek, S. (Principal Investigator (PI)), Kabelitz, D. (Principal Investigator (PI)), Holle, J. (Principal Investigator (PI)), Ehlers, S. (Principal Investigator (PI)) & Moosig, F. (Principal Investigator (PI))

    01.01.0731.12.15

    Project: DFG Joint ResearchDFG Clinical Research Units (CRU)

Cite this